FDA Reports Excess Radiation from PET scan

The U.S. Food and Drug Administration (FDA) is now alerting healthcare professionals to stop using CardioGen-82 (manufactured by Bracco Diagnostics, Inc.) for cardiac positron emission tomography (PET) scans. The FDA reports that patients undergoing a CardioGen-82 PET scan are being exposed to excess radiation. A PET scan is a unique type of imaging test that helps doctors see how the organs are tissues inside your body are actually functioning. A CardioGen-82 PET scan is one of a variety of nuclear medicine scans that use radioactive drugs to evaluate the heart. On July 15, 2011, the FDA alerted the pubic and the medical imaging community about the potential increased radiation exposure in patients who underwent or will be undergoing cardiac PET scans with rubidium (Rb)-82 chloride injections from CardioGen-82. At this time, the FDA has received reports of two patients who received more radiation than expected from CardioGen-82. The FDA believes the risk of harm from this exposure is minimal, although exposure to any excessive radiation is undesirable. The current manufacturing of CardioGen-82 is under review and an investigation of the sufficiency of testing procedures at Bracco’s clinical sites is also taking place. The FDA recommends that healthcare professionals use alternatives to CardioGen-82 when planning for these types of PET scans and is asking that patients talk with their healthcare professionals for any questions or concerns. Source: http://www.fda.gov/Drugs/DrugSafety/ucm265278.htm

Dear Friends and Clients,

In furtherance of our firm’s culture of commitment to always act with compassion, concern and commitment to our clients, community and colleagues, we have been taking precautions to ensure that we are still fulfilling our ethical and moral obligations while prioritizing health, wellness and safety of all we can.

As you know, the COVID-19 pandemic has introduced changes to many lives and businesses in our communities, and around the world. We, much like our neighbors and friends, have been taking precautions to ensure that we are still fulfilling our ethical and moral obligation to our clients, while also prioritizing the health, wellness and safety of our employees.

Until further notice, our offices will be closed to the public to encourage social distancing and to help prevent the spread of COVID-19. Our team is still hard at work, many from home, and you may still call, email, live chat or video conference us if you or a loved one is seeking legal assistance. As the first law firm to offer our clients secure online access to their case file more than a decade ago, we have always been believers in using technology to make life easier and information more accessible. In these present times it has been a smooth transition for us to continue to offer our clients the same seamless and thorough service that you deserve and are accustomed to.

This pandemic is unlike anything any of us have faced in our lifetimes, and while we can continue to emotionally support one another through it all, staying home and keeping your distance is vital to the health and wellness of our communities. It does not feel good to break routines, cancel events and retreat from our normal, day-to-day socializing, but let us remember that, in times of strife, prior generations were asked to go to war and we are simply being asked to stay home. Your isolation equals more lives saved, and more time for medical providers to prepare for the treatment of patients battling COVID-19.

When the dust settles, we will join together with a greater appreciation for our lives, local businesses, loved ones and health. Until then, we will continue to offer guidance from a safe distance.

Very truly yours,

Andrew G. Finkelstein and the staff of Finkelstein & Partners, LLP